Omega-3 Fatty Acids and Health Effects

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stine Marie Ulven, Oslo and Akershus University College of Applied Sciences
ClinicalTrials.gov Identifier:
NCT01034423
First received: December 16, 2009
Last updated: February 3, 2015
Last verified: February 2015
  Purpose

The investigators want to study health effects from omega-3 fatty acids, from fishoil with different quality.


Condition Intervention
Healthy
Dietary Supplement: Omega-3
Dietary Supplement: sun flower oil

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Basic Science
Official Title: Omega-3 Fatty Acids and Health Effects

Resource links provided by NLM:


Further study details as provided by Oslo and Akershus University College of Applied Sciences:

Primary Outcome Measures:
  • Primary and secondary oxidation products [ Time Frame: baseline (0 weeks), 3 weeks and 7 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • inflammatory markers [ Time Frame: after 0,3 and 7 weeks ] [ Designated as safety issue: No ]

Enrollment: 69
Study Start Date: September 2009
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: omega-3 high quality Dietary Supplement: Omega-3
Capsules with omega-3 fatty acids.
Dietary Supplement: sun flower oil
Capsules with sun flower oil.
Experimental: omega-3 low quality Dietary Supplement: Omega-3
Capsules with omega-3 fatty acids.
Dietary Supplement: sun flower oil
Capsules with sun flower oil.
Placebo Comparator: placebo Dietary Supplement: Omega-3
Capsules with omega-3 fatty acids.
Dietary Supplement: sun flower oil
Capsules with sun flower oil.

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy individuals.

Exclusion Criteria:

  • Pregnant women, lactating women, chronic diseases and smoking.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01034423

Sponsors and Collaborators
Oslo and Akershus University College of Applied Sciences
Investigators
Study Chair: Stine M Ulven, PhD Oslo and Akershus University College of Applied Sciences
  More Information

No publications provided by Oslo and Akershus University College of Applied Sciences

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Stine Marie Ulven, Associate Professor, Oslo and Akershus University College of Applied Sciences
ClinicalTrials.gov Identifier: NCT01034423     History of Changes
Other Study ID Numbers: 6.2008.2215
Study First Received: December 16, 2009
Last Updated: February 3, 2015
Health Authority: Norway: Regional Committees for Medical and Health Research Ethics

Keywords provided by Oslo and Akershus University College of Applied Sciences:
Focus: health effects from omega-3 fatty acids, from fish oil with different quality

ClinicalTrials.gov processed this record on July 30, 2015